Biohaven Ltd

BHVNNYSE · USD
12.39USD0.00 (-9.24%)
2310

Biohaven Ltd (BHVN) Covered Calls

Biohaven Ltd trades in the Biotechnology industry with an IV Rank of 61.90%, average versus the past year. BHVN's highest covered call setup is the $15.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 9.89% out of the money with 1 day to expiration, a 10.26% return until expiration, and a 3,743.59% theoretical annualized return. Across the setups shown, annualized returns run from 253.57% to 3,743.59% at strikes between $15.00 and $30.00, with 1 to 148 days to expiration, as of Nov 19, 2026.

Read more

Running BHVN covered calls helps you generate income from Biohaven Ltd shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BHVN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If BHVN stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BHVN covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BHVN covered call is worth writing.

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

2026-11-20115.009.890.050.35140.0010.263743.59-0.37+0.234190.30
2026-12-182922.5064.840.050.35890.0065.20820.64-0.37+0.10410.30
2026-12-182920.0046.520.150.40650.0047.62599.34-1.10+0.142,7430.25
2026-12-182917.5028.210.200.70405.0029.67373.44-1.47+0.234140.50
2027-01-155721.0053.850.050.90740.0054.21347.15-0.37+0.191,3510.85
2027-01-155720.0046.520.350.70670.0049.08314.31-2.56+0.212,1070.35
2027-04-1614830.00119.780.051.601640.00120.15296.31-0.37+0.21481.55
2027-04-1614829.00112.450.203.401555.00113.92280.95-1.47+0.3403.20
2027-04-1614828.00105.130.201.901455.00106.59262.88-1.47+0.2511.70
2026-12-182916.0017.220.400.95275.0020.15253.57-2.93+0.332,4160.55

As of Nov 19, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank61.90% Moderate
  • Market cap (M$)1,872
  • 52 weeks high-32.07%
  • 52 weeks low54.30%
  • Analyst recommendationBuy
    1.75
  • Target price$25.71
    107.51% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-29
  • P/E—
  • Future P/E—
  • EPS (ttm)-3.86
  • EPS growth next 5 years33.85%

As of Nov 20, 2026